{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:40:42Z","timestamp":1792478442537,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12888-018-1827-3","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:38:24Z","timestamp":1533116304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1734-788X","authenticated-orcid":false,"given":"Maria Giuseppina","family":"Petruzzelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Margari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Peschechera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"de Giambattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Giacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Margari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"issue":"8","key":"1827_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1517\/14740338.2014.935761","volume":"13","author":"FM Werner","year":"2014","unstructured":"Werner FM, Covenas R. Safety of antipsychotic drugs: focus on therapeutic and adverse effects. Expert Opin Drug Saf. 2014;13(8):1031\u201342.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"1827_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2215-0366(15)00007-3","volume":"2","author":"M Ward","year":"2015","unstructured":"Ward M, Druss B. The epidemiology of diabetes in psychotic disorders. Lancet Psychiatry. 2015;2(5):431\u201351.","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"1827_CR3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/mp.2008.40","volume":"13","author":"RR Girgis","year":"2008","unstructured":"Girgis RR, Javitch JA, Lieberman JA. Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway. Mol Psychiatry. 2008;13(10):918\u201329.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1827_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/YIC.0000000000000063","volume":"30","author":"L Margari","year":"2015","unstructured":"Margari L, Matera E, Petruzzelli MG, Simone M, Lamanna AL, Pastore A, Palmieri VO, Margari F. Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents. Int Clin Psychopharmacol. 2015;30(2):103\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"1827_CR5","first-page":"175360","volume":"2014","author":"RP Rajkumar","year":"2014","unstructured":"Rajkumar RP. Prolactin and psychopathology in schizophrenia: a literature review and reappraisal. Schizophr Res Treatment. 2014;2014:175360.","journal-title":"Schizophr Res Treatment"},{"issue":"Suppl 2","key":"1827_CR6","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.euroneuro.2008.02.004","volume":"18","author":"AL Montejo","year":"2008","unstructured":"Montejo AL. Prolactin awareness: an essential consideration for physical health in schizophrenia. Eur Neuropsychopharmacol. 2008;18(Suppl 2):S108\u201314.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"1827_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1017\/S1461145714000157","volume":"17","author":"RM Paredes","year":"2014","unstructured":"Paredes RM, Quinones M, Marballi K, Gao X, Valdez C, Ahuja SS, Velligan D, Walss-Bass C. Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome. Int J Neuropsychopharmacol. 2014;17(8):1139\u201348.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"1827_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.euroneuro.2018.01.004","volume":"28","author":"G Scaini","year":"2018","unstructured":"Scaini G, Quevedo J, Velligan D, Roberts DL, Raventos H, Walss-Bass C. Second generation antipsychotic-induced mitochondrial alterations: implications for increased risk of metabolic syndrome in patients with schizophrenia. Eur Neuropsychopharmacol. 2018;28(3):369\u201380.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"1827_CR9","first-page":"177","volume":"28","author":"L Margari","year":"2013","unstructured":"Margari L, Matera E, Craig F, Petruzzelli MG, Palmieri VO, Pastore A, Margari F. Tolerability and safety profile of risperidone in a sample of children and adolescents. Int Clin Psychopharmacol. 2013;28(4):177\u201383.","journal-title":"Int Clin Psychopharmacol"},{"issue":"12","key":"1827_CR10","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1017\/S0033291713000226","volume":"43","author":"A Riecher-Rossler","year":"2013","unstructured":"Riecher-Rossler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW, Group ES. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychol Med. 2013;43(12):2571\u201382.","journal-title":"Psychol Med"},{"issue":"1","key":"1827_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","volume":"134","author":"C Garcia-Rizo","year":"2012","unstructured":"Garcia-Rizo C, Fernandez-Egea E, Oliveira C, Justicia A, Parellada E, Bernardo M, Kirkpatrick B. Prolactin concentrations in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Res. 2012;134(1):16\u20139.","journal-title":"Schizophr Res"},{"issue":"7","key":"1827_CR12","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","volume":"34","author":"J Aston","year":"2010","unstructured":"Aston J, Rechsteiner E, Bull N, Borgwardt S, Gschwandtner U, Riecher-Rossler A. Hyperprolactinaemia in early psychosis-not only due to antipsychotics. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34(7):1342\u20134.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"1827_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.pnpbp.2006.09.016","volume":"31","author":"M Segal","year":"2007","unstructured":"Segal M, Avital A, Berstein S, Derevenski A, Sandbank S, Weizman A. Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(2):378\u201382.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"1827_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","volume":"229","author":"P Petrikis","year":"2015","unstructured":"Petrikis P, Tigas S, Tzallas AT, Papadopoulos I, Skapinakis P, Mavreas V. Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance. Psychiatry Res. 2015;229(3):901\u20134.","journal-title":"Psychiatry Res"},{"issue":"3","key":"1827_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.psychres.2013.08.056","volume":"210","author":"S Chen","year":"2013","unstructured":"Chen S, Broqueres-You D, Yang G, Wang Z, Li Y, Wang N, Zhang X, Yang F, Tan Y. Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia. Psychiatry Res. 2013;210(3):825\u20139.","journal-title":"Psychiatry Res"},{"issue":"1","key":"1827_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.schres.2013.07.051","volume":"150","author":"X Wu","year":"2013","unstructured":"Wu X, Huang Z, Wu R, Zhong Z, Wei Q, Wang H, Diao F, Wang J, Zheng L, Zhao J, et al. The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls. Schizophr Res. 2013;150(1):157\u201362.","journal-title":"Schizophr Res"},{"issue":"2","key":"1827_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/schbul\/sbs134","volume":"39","author":"E Fernandez-Egea","year":"2013","unstructured":"Fernandez-Egea E, Garcia-Rizo C, Zimbron J, Kirkpatrick B. Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view. Schizophr Bull. 2013;39(2):266\u20137.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"1827_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","volume":"102","author":"S Sengupta","year":"2008","unstructured":"Sengupta S, Parrilla-Escobar MA, Klink R, Fathalli F, Ying Kin N, Stip E, Baptista T, Malla A, Joober R. Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls? Schizophr Res. 2008;102(1\u20133):329\u201336.","journal-title":"Schizophr Res"},{"key":"1827_CR19","unstructured":"Kaufman J, Birmaher B, Rao U, Ryan N: Test K-SADS-PL - Intervista diagnostica per la valutazione dei disturbi psicopatologici in bambini e adolescenti Erickson edn; 2004."},{"key":"1827_CR20","first-page":"60","volume":"1","author":"P Pancheri","year":"1995","unstructured":"Pancheri P, Brugnoli R, Carilli L, Delle Chiaie R, Marconi PL, Petrucci RM. Valutazione dimensionale della sintomatologia schizofrenica. Validazione della versione italiana della Scala per la valutazione dei Sintomi Positivi e Negativi (PANSS). Giorn Ital Psicopat. 1995;1:60\u201375.","journal-title":"Giorn Ital Psicopat"},{"issue":"3","key":"1827_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eurpsy.2015.01.010","volume":"30","author":"F Schultze-Lutter","year":"2015","unstructured":"Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RK, Riecher-Rossler A, van der Gaag M, Nordentoft M, Raballo A, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry. 2015;30(3):405\u201316.","journal-title":"Eur Psychiatry"},{"key":"1827_CR22","doi-asserted-by":"crossref","unstructured":"Pelizza L, Paterlini F, Azzali S, Garlassi S, Scazza I, Pupo S, Simmons M, Nelson B, Raballo A. The approved Italian version of the comprehensive assessment of at-risk mental states (CAARMS-ITA): field test and psychometric features. Early Interv Psychiatry. 2018.","DOI":"10.1111\/eip.12669"},{"key":"1827_CR23","series-title":"Versione per bambini e adolescenti","volume-title":"STRUMENTO DI VALUTAZIONE PER LA PROPENSIONE ALLA SCHIZOFRENIA","author":"F Schultze-Lutter","year":"2010","unstructured":"Schultze-Lutter F. In: Fioriti G, editor. STRUMENTO DI VALUTAZIONE PER LA PROPENSIONE ALLA SCHIZOFRENIA, Versione per bambini e adolescenti; 2010."},{"issue":"3\u20134","key":"1827_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000365937","volume":"4","author":"D Shikha","year":"2014","unstructured":"Shikha D, Singla M, Walia R, Potter N, Mercado A, Winer N. Vascular compliance in lean, obese, and diabetic children and adolescents: a cross-sectional study in a minority population. Cardiorenal Med. 2014;4(3\u20134):161\u20137.","journal-title":"Cardiorenal Med"},{"issue":"4","key":"1827_CR25","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1542\/peds.2004-1921","volume":"115","author":"M Keskin","year":"2005","unstructured":"Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose\/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115(4):e500\u20133.","journal-title":"Pediatrics"},{"issue":"1","key":"1827_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000329028","volume":"65","author":"JK Rybakowski","year":"2012","unstructured":"Rybakowski JK, Dmitrzak-Weglarz M, Kapelski P, Hauser J. Functional \u22121149 g\/t polymorphism of the prolactin gene in schizophrenia. Neuropsychobiology. 2012;65(1):41\u20134.","journal-title":"Neuropsychobiology"},{"key":"1827_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.schres.2016.10.029","volume":"182","author":"SA Ivanova","year":"2017","unstructured":"Ivanova SA, Osmanova DZ, Boiko AS, Pozhidaev IV, Freidin MB, Fedorenko OY, Semke AV, Bokhan NA, Kornetova EG, Rakhmazova LD, et al. Prolactin gene polymorphism (\u22121149 G\/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics. Schizophr Res. 2017;182:110\u20134.","journal-title":"Schizophr Res"},{"issue":"5","key":"1827_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1507\/endocrj.K07-003","volume":"54","author":"S Jaroenporn","year":"2007","unstructured":"Jaroenporn S, Nagaoka K, Kasahara C, Ohta R, Watanabe G, Taya K. Physiological roles of prolactin in the adrenocortical response to acute restraint stress. Endocr J. 2007;54(5):703\u201311.","journal-title":"Endocr J"},{"key":"1827_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpsychires.2014.10.011","volume":"60","author":"J Labad","year":"2015","unstructured":"Labad J, Stojanovic-Perez A, Montalvo I, Sole M, Cabezas A, Ortega L, Moreno I, Vilella E, Martorell L, Reynolds RM, et al. Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin. J Psychiatr Res. 2015;60:163\u20139.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"1827_CR30","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.psyneuen.2013.06.030","volume":"38","author":"D Nordholm","year":"2013","unstructured":"Nordholm D, Krogh J, Mondelli V, Dazzan P, Pariante C, Nordentoft M. Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: a systematic review and meta-analysis. Psychoneuroendocrinology. 2013;38(11):2394\u2013404.","journal-title":"Psychoneuroendocrinology"},{"issue":"2 Suppl","key":"1827_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0269881107084020","volume":"22","author":"CM Pariante","year":"2008","unstructured":"Pariante CM. Pituitary volume in psychosis: the first review of the evidence. J Psychopharmacol. 2008;22(2 Suppl):76\u201381.","journal-title":"J Psychopharmacol"},{"issue":"10","key":"1827_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.lfs.2006.11.040","volume":"80","author":"FP MacMaster","year":"2007","unstructured":"MacMaster FP, Keshavan M, Mirza Y, Carrey N, Upadhyaya AR, El-Sheikh R, Buhagiar CJ, Taormina SP, Boyd C, Lynch M, et al. Development and sexual dimorphism of the pituitary gland. Life Sci. 2007;80(10):940\u20134.","journal-title":"Life Sci"},{"issue":"2","key":"1827_CR33","first-page":"TC01","volume":"11","author":"BK Soni","year":"2017","unstructured":"Soni BK, Joish UK, Sahni H, George RA, Sivasankar R, Aggarwal R. A comparative study of pituitary volume variations in MRI in acute onset of psychiatric conditions. J Clin Diagn Res. 2017;11(2):TC01\u20134.","journal-title":"J Clin Diagn Res"},{"key":"1827_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.schres.2016.09.026","volume":"179","author":"AM Greenhalgh","year":"2017","unstructured":"Greenhalgh AM, Gonzalez-Blanco L, Garcia-Rizo C, Fernandez-Egea E, Miller B, Arroyo MB, Kirkpatrick B. Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis. Schizophr Res. 2017;179:57\u201363.","journal-title":"Schizophr Res"},{"issue":"5","key":"1827_CR35","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2337\/diacare.26.5.1333","volume":"26","author":"GP Carnevale Schianca","year":"2003","unstructured":"Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care. 2003;26(5):1333\u20137.","journal-title":"Diabetes Care"},{"issue":"3","key":"1827_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00592-009-0143-2","volume":"47","author":"Y Hu","year":"2010","unstructured":"Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou J, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol. 2010;47(3):231\u20136.","journal-title":"Acta Diabetol"},{"key":"1827_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eurpsy.2016.10.001","volume":"41","author":"C Garcia-Rizo","year":"2017","unstructured":"Garcia-Rizo C, Fernandez-Egea E, Oliveira C, Meseguer A, Cabrera B, Mezquida G, Bioque M, Penades R, Parellada E, Bernardo M, et al. Metabolic syndrome or glucose challenge in first episode of psychosis? Eur Psychiatry. 2017;41:42\u20136.","journal-title":"Eur Psychiatry"},{"issue":"2","key":"1827_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00592-015-0782-4","volume":"53","author":"B Shashaj","year":"2016","unstructured":"Shashaj B, Luciano R, Contoli B, Morino GS, Spreghini MR, Rustico C, Sforza RW, Dallapiccola B, Manco M. Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol. 2016;53(2):251\u201360.","journal-title":"Acta Diabetol"},{"issue":"4","key":"1827_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4274\/Jcrpe.1127","volume":"5","author":"Y Singh","year":"2013","unstructured":"Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245\u201351.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"3\u20134","key":"1827_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000479510","volume":"88","author":"S Bussler","year":"2017","unstructured":"Bussler S, Penke M, Flemming G, Elhassan YS, Kratzsch J, Sergeyev E, Lipek T, Vogel M, Spielau U, Korner A, et al. Novel insights in the metabolic syndrome in childhood and adolescence. Horm Res Paediatr. 2017;88(3\u20134):181\u201393.","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"1827_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5223\/pghn.2018.21.1.59","volume":"21","author":"CA Nogueira-de-Almeida","year":"2018","unstructured":"Nogueira-de-Almeida CA, de Mello ED. Different criteria for the definition of insulin resistance and its relation with dyslipidemia in overweight and obese children and adolescents. Pediatr Gastroenterol Hepatol Nutr. 2018;21(1):59\u201367.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"6","key":"1827_CR42","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5582\/ddt.2015.01207","volume":"9","author":"Q Tang","year":"2015","unstructured":"Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug Discov Ther. 2015;9(6):380\u20135.","journal-title":"Drug Discov Ther"},{"issue":"1","key":"1827_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1758-5996-5-71","volume":"5","author":"J Yin","year":"2013","unstructured":"Yin J, Li M, Xu L, Wang Y, Cheng H, Zhao X, Mi J. Insulin resistance determined by homeostasis model assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;5(1):71.","journal-title":"Diabetol Metab Syndr"},{"key":"1827_CR44","doi-asserted-by":"publisher","first-page":"783296","DOI":"10.1155\/2015\/783296","volume":"2015","author":"R Burrows","year":"2015","unstructured":"Burrows R, Correa-Burrows P, Reyes M, Blanco E, Albala C, Gahagan S. Healthy Chilean Adolescents with HOMA-IR >\/= 2.6 Have Increased Cardiometabolic Risk: Association with Genetic, Biological, and Environmental Factors. J Diabetes Res. 2015;2015:783296.","journal-title":"J Diabetes Res"},{"key":"1827_CR45","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1038\/tp.2016.50","volume":"6","author":"C Gragnoli","year":"2016","unstructured":"Gragnoli C, Reeves GM, Reazer J, Postolache TT. Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. Transl Psychiatry. 2016;6:e785.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"1827_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12020-013-9914-1","volume":"44","author":"I Bernabeu","year":"2013","unstructured":"Bernabeu I, Casanueva FF. Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment? Endocrine. 2013;44(2):273\u20134.","journal-title":"Endocrine"},{"key":"1827_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-12114-7_1","volume":"846","author":"N Ben-Jonathan","year":"2015","unstructured":"Ben-Jonathan N, Hugo E. Prolactin (PRL) in adipose tissue: regulation and functions. Adv Exp Med Biol. 2015;846:1\u201335.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1827_CR48","doi-asserted-by":"publisher","first-page":"e0175204","DOI":"10.1371\/journal.pone.0175204","volume":"12","author":"M Daimon","year":"2017","unstructured":"Daimon M, Kamba A, Murakami H, Mizushiri S, Osonoi S, Yamaichi M, Matsuki K, Sato E, Tanabe J, Takayasu S, et al. Association between serum prolactin levels and insulin resistance in non-diabetic men. PLoS One. 2017;12(4):e0175204.","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"1827_CR49","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar4688","volume":"16","author":"RH Straub","year":"2014","unstructured":"Straub RH. Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases. Arthritis Res Ther. 2014;16(Suppl 2):S4.","journal-title":"Arthritis Res Ther"},{"key":"1827_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2018.02.032","volume":"114","author":"K Blaslov","year":"2018","unstructured":"Blaslov K, Kruljac I, Mirosevic G, Kirigin Bilos LS, Vrkljan M. The possible role of stress induced hormonal disbalance in the patophysiology of insulin resistane in lean individuals. Med Hypotheses. 2018;114:8\u201310.","journal-title":"Med Hypotheses"},{"issue":"2","key":"1827_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3371\/CSRP.KIMI.031513","volume":"8","author":"B Kirkpatrick","year":"2014","unstructured":"Kirkpatrick B, Miller B, Garcia-Rizo C, Fernandez-Egea E. Schizophrenia: a systemic disorder. Clin Schizophr Relat Psychoses. 2014;8(2):73\u20139.","journal-title":"Clin Schizophr Relat Psychoses"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1827-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-018-1827-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1827-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T20:11:25Z","timestamp":1564603885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-018-1827-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1186\/s12888-018-1827-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After providing complete description about the study, we obtained written informed consent from the parents of all subjects. The study was approved by the Ethical Committee of the Hospital Consortium Policlinico of Bari, Italy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All parents of the participants gave written consent to publish all data reported in this and other publications arising from study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"246"}}